Obesity drugs Archives - Pharma Marketing Network

Home Tags Obesity drugs

GLP-1 injection pen creating ripple effects across multiple therapeutic areas including cardiovascular health, diabetes, sleep medicine, orthopedics, kidney disease, and liver health.

The GLP-1 Ripple Effect: How Obesity Drugs Are Rewriting Marketing Strategies...

Donna Pacheco - July 23, 2026

Pharmaceutical researchers and healthcare marketers contrast evidence-based peptide therapies with wellness industry marketing, highlighting trust, science, and responsible communication.

The Peptide Gold Rush: Can Pharma Win Back Trust?

Donna Pacheco - June 30, 2026

Does This Email Message from KVK Tech Violate FDA Regulations?

Pharma Guy - September 28, 2017

A New Unmet Medical Need: Excess Adipose Tissue Syndrome

Pharma Guy - February 3, 2013

Can Obesity Be Treated with Cheap Antibiotics?

Pharma Guy - December 19, 2012

Type 2 Diabetes in Obese Children Proves Difficult to Treat with...

Pharma Guy - April 30, 2012

Should FDA Have Approved Contrave for Obesity Because Docs Are Too...

Pharma Guy - February 4, 2011

Country Music Superstar Judds Corner the Pharma Celebrity Market!

Pharma Guy - January 8, 2009

Social Network Analysis Good for Obesity Drug Marketing and Beyond!

Pharma Guy - July 26, 2007

alli Marketer Explains “Treatment Effects”

Pharma Guy - July 16, 2007

12 Page 1 of 2